Related references
Note: Only part of the references are listed.Probabilistic Logic Methods and Some Applications to Biology and Medicine
Nikita A. Sakhanenko et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2012)
Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiency
Sebastien Jacquemont et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Mechanism of Membrane Interaction and Disruption by α-Synuclein
Nicholas P. Reynolds et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Orally Administrated Cinnamon Extract Reduces β-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer's Disease Animal Models
Anat Frydman-Marom et al.
PLOS ONE (2011)
Drosophila Models of Parkinson's Disease: Discovering Relevant Pathways and Novel Therapeutic Strategies
Veronica Munoz-Soriano et al.
PARKINSONS DISEASE (2011)
Genetic Animal Models of Parkinson's Disease
Ted M. Dawson et al.
NEURON (2010)
Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor
Roni Scherzer-Attali et al.
PLOS ONE (2010)
Inhibiting α-Synuclein Oligomerization by Stable Cell-Penetrating β-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies
Ronit Shaltiel-Karyo et al.
PLOS ONE (2010)
Insulin-degrading enzyme is exported via an unconventional protein secretion pathway
Ji Zhao et al.
MOLECULAR NEURODEGENERATION (2009)
Modelling Parkinson's Disease in Drosophila
Jose A. Botella et al.
NEUROMOLECULAR MEDICINE (2009)
alpha-Synuclein Assembly as a Therapeutic Target of Parkinson's Disease and Related Disorders
Kenjiro Ono et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Pink1 suppresses α-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease
Amy M. Todd et al.
GENOME (2008)
Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease
Kien Trinh et al.
JOURNAL OF NEUROSCIENCE (2008)
Characterization of potential outcome measures for future clinical trials in fragile X syndrome
Elizabeth Berry-Kravis et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2008)
Methionine sulfoxide reductase A and a dietary supplement S-Methyl-L-cysteine prevent Parkinson's-Like symptoms
Ramez Wassef et al.
JOURNAL OF NEUROSCIENCE (2007)
α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
Antony A. Cooper et al.
SCIENCE (2006)
Diagnosis and treatment of Parkinson disease: molecules to medicine
Joseph M. Savitt et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Male-specific fruitless specifies the neural substrates of Drosophila courtship behaviour
DS Manoli et al.
NATURE (2005)
Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome
SMJ McBride et al.
NEURON (2005)
Intraneuronal A beta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease
DC Crowther et al.
NEUROSCIENCE (2005)
Median bundle neurons coordinate behaviours during Drosophila male courtship
DS Manoli et al.
NATURE (2004)
Choosing from competing theories in computerised learning
A Meidan et al.
MINDS AND MACHINES (2002)
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster
RG Pendleton et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Circadian rhythms of female mating activity governed by clock genes in Drosophila
T Sakai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster
LT Reiter et al.
GENOME RESEARCH (2001)
Are complex behaviors specified by dedicated regulatory genes?: Reasoning from Drosophila
BS Baker et al.
CELL (2001)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Share Paper
